These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

99 related items for PubMed ID: 8314962

  • 1. The effects of a gonadotrophin-releasing hormone agonist on treatment with low dose follicle stimulating hormone in polycystic ovary syndrome.
    Scheele F, Hompes PG, van der Meer M, Schoute E, Schoemaker J.
    Hum Reprod; 1993 May; 8(5):699-704. PubMed ID: 8314962
    [Abstract] [Full Text] [Related]

  • 2. The relationship between follicle-stimulating hormone dose and level and its relevance for ovulation induction with adjuvant gonadotropin-releasing hormone-agonist treatment.
    Scheele F, Hompes PG, van der Meer M, Schoute E, Schoemaker J.
    Fertil Steril; 1993 Oct; 60(4):620-5. PubMed ID: 8405514
    [Abstract] [Full Text] [Related]

  • 3. Polycystic ovary syndrome: low-dose follicle stimulating hormone administration is a safe stimulation regimen even in previous hyper-responsive patients.
    Dale PO, Tanbo T, Haug E, Abyholm T.
    Hum Reprod; 1992 Sep; 7(8):1085-9. PubMed ID: 1400931
    [Abstract] [Full Text] [Related]

  • 4. The step-down principle in gonadotrophin treatment and the role of GnRH analogues.
    Fauser BC, Donderwinkel P, Schoot DC.
    Baillieres Clin Obstet Gynaecol; 1993 Jun; 7(2):309-30. PubMed ID: 8358893
    [Abstract] [Full Text] [Related]

  • 5. Growth of the dominant follicle is similar to normal in patients with gonadotrophin-stimulated polycystic ovary syndrome exhibiting monofollicular development during a decremental dose regimen.
    Schoot DC, Hop WC, Pache TD, de Jong FH, Fauser BC.
    Acta Endocrinol (Copenh); 1993 Aug; 129(2):126-9. PubMed ID: 8372596
    [Abstract] [Full Text] [Related]

  • 6. Low-dose follicle stimulating hormone for ovulation induction in polycystic ovary syndrome.
    Strowitzki T, Seehaus D, Korell M, Hepp H.
    J Reprod Med; 1994 Jul; 39(7):499-503. PubMed ID: 7966037
    [Abstract] [Full Text] [Related]

  • 7. The importance of endogenous feedback for monofollicular growth in low-dose step-up ovulation induction with follicle-stimulating hormone in polycystic ovary syndrome: a randomized study.
    van der Meer M, Hompes PG, Scheele F, Schoute E, Popp-Snijders C, Schoemaker J.
    Fertil Steril; 1996 Oct; 66(4):571-6. PubMed ID: 8816618
    [Abstract] [Full Text] [Related]

  • 8. The prognostic value of basal luteinizing hormone:follicle-stimulating hormone ratio in the treatment of patients with polycystic ovarian syndrome by assisted reproduction techniques.
    Tarlatzis BC, Grimbizis G, Pournaropoulos F, Bontis J, Lagos S, Spanos E, Mantalenakis S.
    Hum Reprod; 1995 Oct; 10(10):2545-9. PubMed ID: 8567767
    [Abstract] [Full Text] [Related]

  • 9. Pulsatile gonadotrophin releasing hormone stimulation after medium-term pituitary suppression in polycystic ovary syndrome.
    Scheele F, Hompes PG, van der Meer M, Schoute E, Schoemaker J.
    Hum Reprod; 1993 Nov; 8 Suppl 2():197-9. PubMed ID: 8276960
    [Abstract] [Full Text] [Related]

  • 10. Follicle stimulating hormone (FSH) dynamics of low dose step-up ovulation induction with FSH in patients with polycystic ovary syndrome.
    van der Meer M, Hompes PG, Scheele F, Schoute E, Veersema S, Schoemaker J.
    Hum Reprod; 1994 Sep; 9(9):1612-7. PubMed ID: 7836509
    [Abstract] [Full Text] [Related]

  • 11. The impact of insulin resistance on the outcome of ovulation induction with low-dose follicle stimulating hormone in women with polycystic ovary syndrome.
    Dale PO, Tanbo T, Haug E, Abyholm T.
    Hum Reprod; 1998 Mar; 13(3):567-70. PubMed ID: 9572412
    [Abstract] [Full Text] [Related]

  • 12. Octreotide, a somatostatin analogue, alters ovarian sensitivity to gonadotrophin stimulation as measured by the follicle stimulating hormone threshold in polycystic ovary syndrome.
    van der Meer M, de Boer JA, Hompes PG, Schoemaker J.
    Hum Reprod; 1998 Jun; 13(6):1465-9. PubMed ID: 9688372
    [Abstract] [Full Text] [Related]

  • 13. Ovulation induction with low doses of "pure" follicle stimulating hormone using a fixed protocol in patients with polycystic ovarian disease.
    Bregieiro LO, de Moura MD, Ferriani RA, Bailão LA, de Sá MF.
    Int J Fertil Menopausal Stud; 1993 Jun; 38(3):152-9. PubMed ID: 8348163
    [Abstract] [Full Text] [Related]

  • 14. The effects of gonadotrophin-releasing hormone agonist on follicular development in patients with polycystic ovary syndrome in an in-vitro fertilization and embryo transfer programme.
    Gersak K, Meden-Vrtovec H, Tomazevic T.
    Hum Reprod; 1994 Sep; 9(9):1596-9. PubMed ID: 7836506
    [Abstract] [Full Text] [Related]

  • 15. The effect of low dose human chorionic gonadotropin on follicular response and oocyte maturation in PCOS patients undergoing IVF cycles: a randomized clinical trial of efficacy and safety.
    Ashrafi M, Kiani K, Ghasemi A, Rastegar F, Nabavi M.
    Arch Gynecol Obstet; 2011 Dec; 284(6):1431-8. PubMed ID: 21210134
    [Abstract] [Full Text] [Related]

  • 16. Gonadotrophin therapy for ovulation induction in subfertility associated with polycystic ovary syndrome.
    Nugent D, Vandekerckhove P, Hughes E, Arnot M, Lilford R.
    Cochrane Database Syst Rev; 2000 Dec; (4):CD000410. PubMed ID: 11034687
    [Abstract] [Full Text] [Related]

  • 17. Exploring the recovery phase after treatment with a gonadotrophin-releasing hormone-agonist for ovulation induction in polycystic ovary syndrome: three pilot trials.
    Scheele F, van der Meer M, Lambalk CB, Schoute E, Schoemaker J, Hompes PG.
    Eur J Obstet Gynecol Reprod Biol; 1995 Oct; 62(2):221-4. PubMed ID: 8582500
    [Abstract] [Full Text] [Related]

  • 18. Administration of pure follicle-stimulating hormone during gonadotropin-releasing hormone agonist therapy in patients with clomiphene-resistant polycystic ovarian disease: hormonal evaluations and clinical perspectives.
    Remorgida V, Venturini PL, Anserini P, Lanera P, De Cecco L.
    Am J Obstet Gynecol; 1989 Jan; 160(1):108-13. PubMed ID: 2492145
    [Abstract] [Full Text] [Related]

  • 19. Triggering of ovulation in human menopausal gonadotrophin-stimulated cycles: comparison between intravenously administered gonadotrophin-releasing hormone (100 and 500 micrograms), GnRH agonist (buserelin, 500 micrograms) and human chorionic gonadotrophin (10,000 IU).
    Gerris J, De Vits A, Joostens M, Van Royen E.
    Hum Reprod; 1995 Jan; 10(1):56-62. PubMed ID: 7745071
    [Abstract] [Full Text] [Related]

  • 20. Ovulation of a single dominant follicle during treatment with low-dose pulsatile follicle stimulating hormone in women with polycystic ovary syndrome.
    Polson DW, Mason HD, Saldahna MB, Franks S.
    Clin Endocrinol (Oxf); 1987 Feb; 26(2):205-12. PubMed ID: 3117445
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.